Cargando…
From Monoamine Oxidase Inhibition to Antiproliferative Activity: New Biological Perspectives for Polyamine Analogs
Monoamine oxidases (MAOs) are well-known pharmacological targets in neurological and neurodegenerative diseases. However, recent studies have revealed a new role for MAOs in certain types of cancer such as glioblastoma and prostate cancer, in which they have been found overexpressed. This finding is...
Autores principales: | Nordio, Giulia, Piazzola, Francesco, Cozza, Giorgio, Rossetto, Monica, Cervelli, Manuela, Minarini, Anna, Basagni, Filippo, Tassinari, Elisa, Dalla Via, Lisa, Milelli, Andrea, Di Paolo, Maria Luisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10490032/ https://www.ncbi.nlm.nih.gov/pubmed/37687158 http://dx.doi.org/10.3390/molecules28176329 |
Ejemplares similares
-
Exploring the activity of polyamine analogues on polyamine and spermine oxidase: methoctramine, a potent and selective inhibitor of polyamine oxidase
por: Di Paolo, Maria Luisa, et al.
Publicado: (2019) -
Polyamine–Drug Conjugates: Do They Boost Drug Activity?
por: Basagni, Filippo, et al.
Publicado: (2023) -
Double Attack to Oxidative Stress in Neurodegenerative Disorders: MAO-B and Nrf2 as Elected Targets
por: Basagni, Filippo, et al.
Publicado: (2023) -
Promising Non-cytotoxic Monosubstituted Chalcones
to Target Monoamine Oxidase-B
por: Iacovino, Luca G., et al.
Publicado: (2021) -
Novel Polyamine–Naphthalene Diimide Conjugates
Targeting Histone Deacetylases and DNA for Cancer Phenotype Reprogramming
por: Pasini, Alice, et al.
Publicado: (2017)